default author photo

Ludvig André Munthe

University of Oslo - KG Jebsen Centre for B Cell Malignancies

Norway

SCHOLARLY PAPERS

3

DOWNLOADS

247

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

T Cell Responses to Repeated SARS-CoV-2 Vaccination and Breakthrough Infections in Patients on TNF Inhibitor Treatment: A Prospective Cohort Study

Number of pages: 27 Posted: 05 Feb 2024
Norwegian Institute of Public Health, Akershus University Hospital, Diakonhjemmet Hospital, Norwegian Institute of Public Health, Norwegian Institute of Public Health, Norwegian Institute of Public Health, Diakonhjemmet Hospital, Norwegian Institute of Public - Department of Infectious Disease Surveillance and Environmental Health, Norwegian Institute of Public Health, Diakonhjemmet Hospital, Norwegian Institute of Public Health, University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - Akershus University Hospital, Diakonhjemmet Hospital, Diakonhjemmet Hospital, Diakonhjemmet Hospital, Akershus University Hospital, University of Oslo, University of Oslo - Institute of Clinical Medicine, University of Oslo - Institute of Clinical Medicine, Diakonhjemmet Hospital - Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), University of Oslo, University of Oslo - Department of Immunology and Transfusion Medicine, University of Oslo - KG Jebsen Centre for B Cell Malignancies, Diakonhjemmet Hospital, Diakonhjemmet Hospital, Akershus University Hospital and Norwegian Institute of Public Health - Department of Method Development and Analytics
Downloads 97 (704,534)

Abstract:

Loading...

TNF inhibitors, tumour necrosis factor inhibitor, SARS-CoV-2, vaccination, T cells, polyfunctionality, inflammatory bowel disease, arthritis

2.

Safety of Baricitinib in Vaccinated Patients with Severe and Critical COVID-19. Sub Study of the Randomised Bari-SolidAct Trial

Number of pages: 30 Posted: 19 Jul 2024
University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, Lyon Sud Hospital, University of Lille, Hospital Universitario La Paz, Hospices Civils de Lyon, University of Claude Bernard Lyon 1, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Nantes - INSERM, University of Nantes - INSERM, University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, University of Oslo - Department of Immunology and Transfusion Medicine, University of Oslo - Institute of Clinical Medicine, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, Amiens Picardie University Hospital - Intensive Care Unit, Hospices Civils de Lyon - Service de Médecine Intensive-Réanimation, University of Bordeaux - CHU de Bordeaux, University of Bordeaux - CHU de Bordeaux, Assistance Publique-Hôpitaux de Paris - Service de Réanimation Médicale Et Infectieuse (MI2), Université Paris Cité, Louis Mourier Hospital, Dijon University Hospital - Clinical Epidemiology Unit, University of Nantes - INSERM, Centro Hospitalar Universitário de Lisboa Central, University of Oslo, Vestre Viken Hospital Trust, Vestre Viken Hospital Trust, University of Stavanger - Stavanger University Hospital, University of Oslo - Oslo University Hospital, University Hospital North Norway, Østfold Hospital Kalnes - Department of Infectious Diseases, University of Oslo - Oslo University Hospital, University of Oslo - Institute of Clinical Medicine, University of Oslo - Oslo University Hospital, University of Oslo - Oslo University Hospital, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Hôpital Bichat - Claude-Bernard - INSERM, IAME Infectious Diseases Department, University of Oslo - Oslo University Hospital, University of Oslo - Division of Emergencies and Critical Care, University of Oslo - Oslo University Hospital, University of Oslo - Institute of Clinical Medicine and University of Oslo - Section for Clinical Immunology and Infectious Diseases
Downloads 94 (720,278)

Abstract:

Loading...

COVID-19, vaccination, baricitinib, JAK inhibitors, immunomodulation, elderly

3.

Preexisting Cross-Reactive T Cells are Boosted and Comprise Significant Immunity in COVID-19 Recovered Patients

Number of pages: 55 Posted: 24 Feb 2021
University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - Institute of Clinical Medicine, Vestre Viken Hospital Trust, Oslo University Hospital - Department of Immunology, University of Oslo - Department of Immunology and Transfusion Medicine, Oslo University Hospital - Department of Microbiology, Norwegian Institute of Public - Department of Infectious Disease Surveillance and Environmental Health, Norwegian Institute of Public Health - Department of Method Development and Analytics, University of Oslo - Institute of Clinical Medicine and University of Oslo - KG Jebsen Centre for B Cell Malignancies
Downloads 56 (1,000,027)
Citation 1

Abstract:

Loading...